Testing effectiveness (Phase 2)UnknownNCT05314101
What this trial is testing
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
Who this might be right for
ImmunotherapyColorectal Cancer
Fujian Cancer Hospital 25